However, the overall expression of MCP-1 and its receptor CCR2 seems to be increased in the liver of mice and patients with NAFLD [134, 135], particularly in its advanced stages [136, 137]. Here, CCR2 is linked to metabolic dysfunction-associated steatotic liver disease.